sur IKONISYS (EPA:ALIKO)
Ikonisys: New international patent for Hospitex
Ikonisys SA announces that Hospitalex International has obtained an international patent for the BLOCKfast cytoinclusion kit. This device, used for the treatment of cells in histology, stands out for its efficiency and innovation compared to traditional methods. Already well established in the Italian market, BLOCKfast shows promising growth globally.
The kit is produced in Florence with advanced chemical processes and rigorous quality controls. Obtaining this international patent, previously marked “in progress”, now allows wider distribution and accessibility of innovative solutions in cancer diagnosis.
This advancement is significant for Hospitex, underscoring its commitment to developing high-performance diagnostic solutions for cancer, with many more patents planned for the future.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de IKONISYS